A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib

TitleA Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib
Publication TypeJournal Article
Year of Publication2019
AuthorsSharma, GG, Cortinovis, D, Agustoni, F, Arosio, G, Villa, M, Cordani, N, Bidoli, P, Bisson, WH, Pagni, F, Piazza, R, Gambacorti-Passerini, C, Mologni, L
JournalJournal of Thoracic Oncology
Volume14
Issue11
Paginatione257 - e259
Date PublishedJan-11-2019
ISSN15560864
URLhttps://linkinghub.elsevier.com/retrieve/pii/S1556086419305921
DOI10.1016/j.jtho.2019.06.028
Short TitleJournal of Thoracic Oncology